Drawing for EMPOWER PHARMA

USPTO serial 98666654

EMPOWER PHARMA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMPOWER PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John A. Yates

John A. Yates Patterson + Sheridan, LLP24 Greenway PlazaSuite 1600Houston, TX 77046

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition, injectable therapy, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, women's health, and gender-affirming care; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes.ACTIVE—
010Medical syringes; disposable syringes; injection syringes, namely, syringe barrels and luer lock syringe barrels; injection needles for medical use; trocars; and containers especially adapted for the disposal of medical instruments and syringesACTIVE—
040Custom manufacture of pharmaceuticals; contract manufacturing of pharmaceuticals; contract manufacturing for others; contract manufacturing for others in the field of pharmacology, microbiology, toxicology, and biotechnologyACTIVE—
042Pharmaceutical drug development services and contract pharmaceutical drug development services; Research and development services of pharmaceutical products and preparations; Research and development services of pharmaceutical products and preparations for others; Conducting research, formulation development, clinical trials, commercial production, packaging, supply chain management, quality assurance, regulatory compliance, and post-marketing product support for others in the pharmaceutical industry in the field of pharmaceuticals; Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Laboratory analysis for others in the field of pharmaceuticals; Laboratory services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing of pharmaceutical raw materials to determine conformity with established regulatory standardsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 24, 2025MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jan 24, 2025ABN1ABANDONMENT - EXPRESS MAILED—
Jan 23, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jan 12, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance